The sick building syndrome as a part of the autoimmune (auto-inflammatory) syndrome induced by adjuvants

References

• Fanger PO. Hidden olfs in sick buildings. ASHRAE. 1988;30:40–3.
   Google Scholar
• WHO. Indoor air quality research. EURO Rep Stud. 1986;103: 1–64.
   Google Scholar
• Norback D. An update on sick building syndrome. Curr Opin Allergy Clin Immunol. 2009;9:55–9.
   PubMed Web of Science ®Google Scholar
• Finnegan MJ, Pickering CA, Burge PS. The sick building syn-drome: prevalence studies. Br Med J (Clin Res Ed). 1984;289:1573–5.
   Google Scholar
• Brasche S, Bullinger M, Morfeld M, Gebhardt HJ, Bischof W. Why do women suffer from sick building syndrome more often than men? Subjective higher sensitivity versus objective causes. Indoor Air. 2001;11:217–22.
   Google Scholar
• Stenberg B, Wall S. Why do women report 'sick building symptoms' more often than men? Soc Sci Med. 1995;40: 491–502.
   Google Scholar
• Burge S, Hedge A, Wilson S, Bass JH, Robertson A. Sick building syndrome: a study of 4373 office workers. Ann Occup Hyg. 1987;31: 493–504.
   Google Scholar
• Bardana EJ Jr, Montanaro A, O'Hollaren MT. Building-related illness. A review of available scientific data. Clin Rev Allergy. 1988;6:61–89.
   Google Scholar
• Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y. Adjuvants and autoimmunity. Lupus. 2009;18:1217–25.
   PubMed Web of Science ®Google Scholar
• Nancy AL, Shoenfeld Y. Chronic fatigue syndrome with auto-antibodies-the result of an augmented adjuvant effect of hepatitis-B vaccine and silicone implant. Autoimmun Rev. 2008;8:52–5.
   PubMedGoogle Scholar
• Shoenfeld Y, Agmon-Levin N. "ASIA"-autoimmune (auto-inflammatory) syndrome induced by adjuvant. J Autoimmun. 2010; [Epub ahead of print].
   Google Scholar
• Chang CC, Ruhl RA, Halpern GM, Gershwin ME. Building com-ponents contributors of the sick building syndrome. J Asthma. 1994;31:127–37.
   PubMed Web of Science ®Google Scholar
• Ruhl RA, Chang CC, Halpern GM, Gershwin ME. The sick building syndrome. II. Assessment and regulation of indoor air quality. J Asthma. 1993;30:297–308.
   Google Scholar
• Assoulin-Daya Y, Leong A, Shoenfeld Y, Gershwin ME. Studies of sick building syndrome. IV. Mycotoxicosis. J Asthma. 2002;39:191–201.
   PubMedGoogle Scholar
• Schutze N, Lehmann I, Bonisch U, Simon JC, Polte T. Exposure to mycotoxins increases the allergic immune response in a murine asthma model. Am J Respir Crit Care Med. 2010;181:1188–99.
   Google Scholar
• Straus DC. Molds, mycotoxins, and sick building syndrome. Toxicol Ind Health. 2009;25:617–35.
   PubMedGoogle Scholar
• Meggs WJ. RADS and RUDS-the toxic induction of asthma and rhinitis. J Toxicol Clin Toxicol. 1994;32:487–501.
   PubMed Web of Science ®Google Scholar
• Steerenberg PA, Withagen CE, Dormans JA, van Dalen WJ, van Loveren H, Casee FR. Adjuvant activity of various diesel exhaust and ambient particles in two allergic models. J Toxicol Environ Health A. 2003;66:1421–39.
   Google Scholar
• Diaz-Sanchez D, Tsien A, Fleming J, Saxon A. Combined diesel exhaust particulate and ragweed allergen challenge markedly enhances human in vivo nasal ragweed-specific IgE and skews cytokine production to a T helper cell 2-type pattern. J Immunol. 1997;158: 2406–13.
   Google Scholar
• Li N, Wang M, Bramble LA, Schmitz DA, Schauer JJ, Sioutas C, et al. The adjuvant effect of ambient particulate matter is closely reflected by the particulate oxidant potential. Environ Health Perspect. 2009;117:1116–23.
   PubMed Web of Science ®Google Scholar
• Schober W, Lubitz S, Belloni B, Gebauer G, Lintelmann J, Matuschek G, et al. Environmental polycyclic aromatic hydro-carbons (PAHs) enhance allergic inflammation by acting on human basophils. Inhal Toxicol. 2007;19(Suppl 1):151–6.
   PubMedGoogle Scholar
• Barsky AJ, Borus JF. Functional somatic syndromes. Ann Intern Med. 1999;130:910–21.
   PubMed Web of Science ®Google Scholar
• Kipen HM, Fiedler N. Environmental factors in medically unex-plained symptoms and related syndromes: the evidence and the challenge. Environ Health Perspect. 2002;110(Suppl 4):597–9.
   PubMedGoogle Scholar
• Binder LM, Campbell KA. Medically unexplained symptoms and neuropsychological assessment. J Clin Exp Neuropsychol. 2004;26:369–92.
   PubMed Web of Science ®Google Scholar
• Chang C, Gershwin ME. Indoor air quality and human health: truth vs mass hysteria. Clin Rev Allergy Immunol. 2004;27:219–39.
   PubMedGoogle Scholar
• Chang CC, Ruhl RA, Halpern GM, Gershwin ME. The sick building syndrome. I. Definition and epidemiological consider-ations. J Asthma. 1993;30:285–95.
   Google Scholar
• Mahmoudi M, Gershwin ME. Sick building syndrome. III. Stachybotrys chartarum. J Asthma. 2000;37:191–8.
   PubMed Web of Science ®Google Scholar
• Tsai YJ, Gershwin ME. The sick building syndrome: what is it when it is? Compr Ther. 2002;28:140–4.
   Google Scholar
• Garabrant DH, Dumas C. Epidemiology of organic solvents and connective tissue disease. Arthritis Res. 2000;2:5–15.
   PubMedGoogle Scholar
• Molina V, Shoenfeld Y. Infection, vaccines and other environ-mental triggers of autoimmunity. Autoimmunity. 2005;38:235–45.
   PubMed Web of Science ®Google Scholar
• Kanazawa A, Kishi R. Potential risk of indoor semivolatile organic compounds indoors to human health. Nippon Eiseigaku Zasshi. 2009;64:672–82.
   PubMedGoogle Scholar
• Koren HS, Graham DE, Devlin RB. Exposure of humans to a volatile organic mixture. III. Inflammatory response. Arch Environ Health. 1992;47:39–44.
   PubMed Web of Science ®Google Scholar
• Agmon-Levin N, Paz Z, Israeli E, Shoenfeld Y. Vaccines and autoimmunity. Nat Rev Rheumatol. 2009;5:648–52.
   PubMed Web of Science ®Google Scholar
• Bar-Meir E, Eherenfeld M, Shoenfeld Y. Silicone gel breast implants and connective tissue disease-a comprehensive review. Autoimmunity. 2003;36:193–7.
   Google Scholar
• Zandman-Goddard G, Blank M, Ehrenfeld M, Gilburd B, Peter J, Shoenfeld Y. A comparison of autoantibody production in asymptomatic and symptomatic women with silicone breast implants. J Rheumatol. 1999;26:73–7.
   Google Scholar
• Campbell AW, Thrasher JD, Madison RA, Vojdani A, Gray MR, Johnson A. Neural autoantibodies and neurophysiologic abnor-malities in patients exposed to molds in water-damaged build-ings. Arch Environ Health. 2003;58:464–74.
   PubMed Web of Science ®Google Scholar
• Cooley JD, Wong WC, Jumper CA, Hutson JC, Williams RI, Schwab CJ, et al. An animal model for allergic penicilliosis induced by the intranasal instillation of viable Penicillium chrysogenum conidia. Thorax. 2000;55:489–96.
   PubMed Web of Science ®Google Scholar
• Gray MR, Thrasher JD, Crago R, Madison RA, Arnold L, Campbell AW, et al. Mixed mold mycotoxicosis: immunological changes in humans following exposure in water-damaged build-ings. Arch Environ Health. 2003;58:410–20.
   PubMedGoogle Scholar
• Lander F, Meyer HW, Norn S. Serum IgE specific to indoor moulds, measured by basophil histamine release, is associated with building-related symptoms in damp buildings. Inflamm Res. 2001;50:227–31.
   Google Scholar
• Meggs WJ. Neurogenic switching: a hypothesis for a mechanism for shifting the site of inflammation in allergy and chemical sensitivity. Environ Health Perspect. 1995;103:54–6.
   PubMed Web of Science ®Google Scholar